| Financial Year |
March 31 2023 |
| Monetary Funds |
145,328,711.30 |
| Held-for-trading Financial Assets |
80,669,316.53 |
| Notes Receivable |
-- |
| Accounts Receivable |
276,370,126.79 |
| Advances to Suppliers |
4,811,131.52 |
| Other Receivables |
46,806,875.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,105,850.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,313,480.65 |
| Total Current Assets |
1,078,324,384.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,481,238.51 |
| Investment Properties |
-- |
| Fixed Assetes |
34,515,598.06 |
| Under-construction Projects |
45,267,702.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,621,900.50 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
12,524,197.26 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
220,271,431.89 |
| Total Assets |
1,298,595,816.55 |
| Short-Term Loans |
80,092,511.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,595,704.98 |
| Accounts Payable |
307,317,375.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,889,832.48 |
| Taxes Payable |
2,302,372.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
234,964.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,001,420.83 |
| Other Current Liabilities |
19,037,861.30 |
| Sub-Total of Current Liabilities |
447,056,612.05 |
| Long-term Loans |
3,004,262.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
360,974.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,365,236.58 |
| Total Liabilities |
450,421,848.63 |
| Paid-In Capital(Or Share Stock) |
140,010,000.00 |
| Capital Surplus |
314,707,853.70 |
| Surplus Reserve |
40,332,622.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
353,125,104.82 |
| Minority Stockholder's Interest |
-1,613.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
848,175,581.14 |
| Owner's Equity（Stockholder's Equity） |
848,173,967.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,298,595,816.55 |
